By popular demand, IBC's Vaccine Development & Production Summit is coming back to Boston on December 8-9, 2014. Improve yield and reduce cost in your vaccine production by hearing industry leaders present new case studies and unpublished data over two days of learning and networking. Bookmark this page and check back often as we update the site with 2014 program information.
Exclusive Interview with Manon M.J. Cox, President and CEO, Protein Sciences Corporation
Protein Sciences Corporation developed the world's first recombinant, highly purified, egg-free influenza vaccine, Flublok®, which the FDA regards as a technological advance in the manufacturing of an influenza vaccine.
Listen to a 7 minute exclusive interview with Manon M.J. Cox.: